Coronary computed tomography in coronary risk assessment

Journal of Cardiopulmonary Rehabilitation

Volumn 25, Issue 1, 2005, Pages 3-10

  Greenland, Philip ^a   Kizilbash, Mohammad Ali ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; ELECTRON BEAM TOMOGRAPHY; EXERCISE; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRACTICE GUIDELINE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; SMOKING; UNITED STATES;

EID: 14644414858     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-200501000-00002     Document Type: Review

References (36)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Chobanian A, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
3. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
4. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. AHA/ACC scientific statement. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 1999;34:1348-1359.
5. U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events. Available at: http://www.ahrq.gov/clinic/uspstf/ uspsasmi.htm. Accessed August 1, 2004.
6. Grover SA, Coupal L, Hu XP. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA. 1995;274:801-806.
7. Milne R, Gamble G, Whitlock G, Jackson R. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors. N Z Med J. 2003;116(1185):U663.
8. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004;148:16-26.
9. Greenland P, Knoll MD, Stamler J. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891-897.
10. Grundy SM. Coronary plaque as a replacement for age as a risk factor in global risk assessment. Am J Cardiol. 2001;88:8E-11E.
11. O'Rourke RA, Brundage BH, Froelicher, et al. American College of Cardiology/American Heart Association Expert Consensus Document on Electron-Beam Computed Tomography for the Diagnosis and Progression of Coronary Artery Disease. Circulation. 2000;02:126-140.
12. Agatston AS, Spadaro LA, Goodman KJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
13. Schoepf UJ, Becker CR, Hofmann LK, Yucel EK. Multidetectorrow CT of the heart. Radiol Clin North Am. 2003;41:491-505.
14. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification. Pathophysiology, epidemiology, imaging methods, and clinical implications: a statement for health professionals from the American Heart Association: writing group. Circulation. 1996;94:1175-1192.
15. Stanford W, Thompson BH, Weiss RM. Coronary artery calcification: clinical significance and current methods of detection. AJR Am J Roentgenol. 1993;161:1139-1146.
16. Doherty TM, Detrano RC, Mautner SL, Mautner GC, Shavelle RM. Coronary calcium: the good, the bad, and the uncertain. Am Heart J. 1999;137:806-814.
17. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation. 2001;104:1682-1687.
18. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and sudden coronary death. Circulation. 1989;80:1747-1756.
19. Schmermund A, Baumgart D, Adamzik M, et al. Comparison of electron beam computed tomography and intracoronary ultrasound in detecting calcified and noncalcified plaques in patients with acute coronary syndromes and no or minimal to moderate angiographic coronary artery disease. Am J Cardiol. 1998;81:141-146.
20. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PP, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995;92:2157-2162.
21. Guerci AD, Spadaro LA, Popma JJ, et al. Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol. 1997;79:128-133.
22. Smith SC, Greenland P, Grundy SM. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. Circulation. 2000;101:111-116.
23. Hecht HS. Practice guidelines for electron beam tomography: a report of the Society of Atherosclerosis Imaging. Am J Cardiol. 2000;86:705-706
24. O'Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol. 2000;85:945-948.
25. Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med. 2004;164:1285-1292.
26. Shaw L, Raggi P, Schisterman E, Berman D, Callister T. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826-833.
27. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events. Circulation. 2003;107:2571-2576.
28. Greenland P, LaBree L, Azen S, Doherty T, Detrano R. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.
29. Shemesh J, Morae-Koren N, Goldbourt U, et al. Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens. 2004;22:605-610.
30. Raggi P, Cooil B, Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J. 2001;141:375-382.
31. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000;36:1253-1260.
32. Momtahan K, Berkman J, Sellick J, Kearns SA, Lauzon N. Patients' understanding of cardiac risk factors: a point-prevalence study J Cardiovasc Nurs. 2004;19:13-20.
33. Kirkland SA, MacLean DR, Langille DB, Joffres MR, MacPherson KM, Andreou P. Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992. CMAJ. 1999;161(suppl 8):S10-S16.
34. Detrano R, Wong ND, Doherty T, et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation. 1999;99:2633-2638.
35. Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 2004;43:1791-1796.
36. Collins R, Armitage J, Parish S, Sleigh P, Peto R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with dia-betes: a randomized placebo-controlled trial. Lancet. 003;361:2005-2016.